Coffin-Lowry syndrome

European Journal of Human Genetics

Volumn 18, Issue 6, 2010, Pages 627-633

  Marques Pereira, Patricia ^a   Schneider, Anne ^a   Pannetier, Solange ^a   Heron, Delphine ^b   Hanauer, André ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PHOSPHOTRANSFERASE; PROTEIN RPS6KA3; PROTEIN RSK2; UNCLASSIFIED DRUG;

CHROMOSOME XP; COFFIN LOWRY SYNDROME; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; FACE MALFORMATION; GENE MUTATION; GENETIC COUNSELING; GROWTH RETARDATION; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; REVIEW; RNA TRANSLATION; SKELETON MALFORMATION; X LINKED MENTAL RETARDATION;

EID: 77952668959     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.189     Document Type: Review

References (38)

1. Coffin GS, Siris E, Wegenkia LC: Mental retardation with osteocartilaginous anomalies. Am J Dis Child 1966; 112: 205-213.
2. Lowry B, Miller J R, Fraser FC: A new dominant gene mental retardation syndrome. Am J Dis Child 1971; 121: 496-500.
3. Temtamy SA, Miller JD, Hussels-Maumenee I: The Coffin-Lowry syndrome: an inherited faciodigital mental retardation syndrome. J Pediatr 1975; 86: 724-731.
4. Hanauer A, Young ID: Coffin-Lowry syndrome: clinical and molecular features. J Med Genet 2002; 39: 705-713. (Pubitemid 35178719)
5. Manouvrier-Hanu S, Amiel J, Jacquot S et al: Unreported RSK2 missense mutation in two male sibs with an unusually mild form of Coffin-Lowry syndrome. J Med Genet 1999; 36: 775-778. (Pubitemid 29462323)
6. Merienne K, Jacquot S, Pannetier S et al: A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nat Genet 1999; 22: 13-14. (Pubitemid 29214794)
7. Field M, Tarpey P, Boyle J et al: Mutations in the RSK2(RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation. Clin Genet 2006; 70: 509-515. (Pubitemid 44741473)
8. Gilgenkrantz S, Mujica P, Gruet P et al: Coffin-Lowry syndrome: a multicenter study. Clin Genet 1988; 34: 230-245.
9. Hunter AG: Coffin-Lowry syndrome: a 20-year follow-up and review of long-term outcomes. Am J Med Genet 2002; 111: 345-355.
10. Stephenson JB, Hoffman MC, Russell AJ et al: The movement disorders of Coffin-Lowry syndrome. Brain Dev 2005; 27: 108-113.
11. Kesler SR, Simensen RJ, Voeller K et al: Altered neurodevelopment associated with mutations of RSK2: a morphometric MRI study of Coffin-Lowry. Neurogenetics 2007; 8: 143-147. (Pubitemid 46356252)
12. Zeniou M, Pannetier S, Fryns JP, Hanauer A: Unusual splice-site mutations in the RSK2 gene and suggestion of genetic heterogeneity in Coffin-Lowry syndrome. Am J Hum Genet 2002; 70: 1421-1433. (Pubitemid 34533890)
13. Simensen RJ, Abidi F, Collins JS et al: Cognitive function in Coffin-Lowry syndrome. Clin Genet 2002; 61: 299-304. (Pubitemid 36372651)
14. Trivier E, De Cesare D, Jacquot S et al: Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 1996; 384: 567-570. (Pubitemid 26415934)
15. Jacquot S, Merienne K, De Cesare D et al: Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations. Am J Hum Genet 1998; 63: 1631-1640. (Pubitemid 30415725)
16. Delaunoy JP, Dubos A, Marques Pereira P, Hanauer A: Identification of novel mutations in the RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. Clin Genet 2006; 70: 161-166. (Pubitemid 44028103)
17. Marques Pereira P, Heron D, Hanauer A: The first large duplication of the RSK2 gene identified in a Coffin-Lowry syndrome patient. Hum Genet 2007; 122: 541-543. (Pubitemid 350148966)
18. Madrigal I, Rodriguez-Revenga L, Armengol L et al: X-chromosome tiling path array detection of copy number variants in patients with chromosome X-linked mental retardation. BMC Genomics 2007; 8: 443. (Pubitemid 351681395)
19. Martinez-Garay I, Ballesta MJ, Oltra S et al: Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome. Clin Genet 2003; 64: 491-496. (Pubitemid 37493119)
20. Nakamura M, magata T, Mori M, Momoi MY: RSK2 gene mutations in Coffin-Lowry syndrome with drop episodes. Brain Dev 2005; 27: 114-117.
21. Hauge C, Frodin M: RSK and MSK in MAP kinase signalling. J Cell Sci 2006; 119: 3021-3023. (Pubitemid 44322115)
22. Zeniou M, Ding T, Trivier E, Hanauer A: Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning. Hum Mol Genet 2002; 11: 2929-2940.
23. Kang S, Elf S, Dong S et al: Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation. Mol Cell Biol 2009; 29: 2105-2117.
24. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P: Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci USA 1998; 95: 12202-12207. (Pubitemid 28483743)
25. Zeniou-Meyer M, Liu Y, Béglé A et al: The Coffin-Lowry syndrome-associated protein RSK2 is implicated in calcium-regulated exocytosis through the regulation of PLD1. Proc Natl Acad Sci USA 2008; 105: 8434-8439. (Pubitemid 351904774)
26. Yang X, Matsuda K, Bialek P et al: ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry syndrome. Cell 2004; 117: 387-398. (Pubitemid 38534544)
27. Strachan RT, Sheffler DJ, Willard B et al: Ribosomal S6 kinase 2 directly phosphor-ylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signaling. J Biol Chem 2009; 284: 5557-5573.
28. Thomas GM, Rumbaugh GR, Harrar DB, Huganir RL: Ribosomal S6 kinase 2 interacts with and phosphorylates PDZ domain-containing proteins and regulates AMPA receptor transmission. Proc Natl Acad Sci USA 2005; 102: 15006-15011.
29. Eisinger-Mathason TS, Andrade J, Groehler AL et al: Codependent functions of RSK2 and the apoptosis-promoting factor TIA-1 in stress granule assembly and cell survival. Mol Cell 2008; 31: 722-736.
30. Poirier R, Jacquot S, Vaillend C et al: Deletion of the Coffin-Lowry syndrome gene Rsk2 in mice is associated with impaired spatial learning and reduced control of exploratory behavior. Behav Genet 2007; 37: 31-50. (Pubitemid 46144051)
31. Marques Pereira P, Gruss M, Braun K et al: Dopaminergic system dysregulation in the mrsk2-KO mouse, an animal model of the Coffin-Lowry syndrome. J Neurochem 2008; 107: 1325-1334.
32. Dufresne SD, Bjorbaek C, El-Haschimi K et al: Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol Cell Biol 2001; 21: 81-87.
33. Putz G, Bertolucci F, Raabe T et al: The S6KII (rsk) gene of Drosophila melanogaster differentially affects an operant and a classical learning task. J Neurosci 2004; 24: 9745-9751. (Pubitemid 39463555)
34. Fischer M, Raabe T, Heisenberg M, Sendtner M: Drosophila RSK negatively regulates bouton number at the neuromuscular junction. Dev Neurobiol 2009; 69: 212-220.
35. Micheli V, Sestini S, Parri V et al: RSK2 enzymatic assay as a second diagnostic tool in Coffin-Lowry syndrome. Clin Chim Acta 2007; 384: 35-40. (Pubitemid 47247408)
36. Jacquot S, Merienne K, Pannetier S et al: Germline mosaicism in Coffin-Lowry syndrome. Eur J Hum Genet 1998; 6: 578-582. (Pubitemid 29020791)
37. Horn D, Delaunoy JP, Kunze J: Prenatal diagnosis in Coffin-Lowry syndrome demonstrates germinal mosaicism confirmed by mutation analysis. Prenat Diagn 2001; 21: 881-884. (Pubitemid 33064087)
38. Hunter AG: Coffin-Lowry syndrome; in Cassidy S, Allanson J (eds): Management of Genetic Syndromes, 2nd edn. Hoboken, NJ: Wiley-Liss, 2005; 127-138.